Finance

Lists
TMDX:NASDAQ
TransMedics Group Inc
84,07 USD
+1,62%
(+1,34) 1D
84,07 USD
0,00% (0,00)
After hours
Closed: 29-сен., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TMDX...
Open
82,56 USD
High
84,22 USD
Low
81,76 USD
Mkt. cap
2,92 млд
Avg. vol.
698,27 миң
Volume
440,18 миң
P/E ratio
21,87
52-wk high
156,00 USD
52-wk low
60,10 USD
EPS
3,84 USD
Beta
1,90
Shares outstanding
34,68 млн
No. of employees
898
Open
82,56 USD
High
84,22 USD
Low
81,76 USD
Mkt. cap
2,92 млд
Avg. vol.
698,27 миң
Volume
440,18 миң
P/E ratio
21,87
52-wk high
156,00 USD
52-wk low
60,10 USD
EPS
3,84 USD
Beta
1,90
Shares outstanding
34,68 млн
No. of employees
898
News stories
From web sources and news partners
About TransMedics Group Inc
CEO-
Employees898
Founded1998
HeadquartersАндовер, Массачусетс, Америка Кошмо Штаттары
SectorMedical device
Websitetransmedics.com
Analyst ratings
Based on 11 analysts giving stock ratings to TMDX in the past 3 months
Buy
Buy
7
Hold
4
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for TMDX in the last 3 months.
Highest
Current 84,07 USD
122,00 USD (+45,12%)
Average
94,22 USD (+12,07%)
Lowest
65,00 USD (-22,68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Matson
Needham
Buy
Reiterated
106,00 USD
+26,1%
09/22/2026
Thomas Stephan
Stifel Nicolaus
Hold
Maintained
65,00 USD
-22,7%
09/11/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
100,00 USD
+18,9%
09/11/2026
William Plovanic
Canaccord Genuity
Buy
Maintained
95,00 USD
+13%
09/11/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
09/10/2026
Josh Jennings
TD Cowen
Buy
Reiterated
120,00 USD
+42,7%
09/08/2026
Suraj Kalia
Oppenheimer
Hold
Maintained
-
-
08/24/2026
Allen Gong
J.P. Morgan
Hold
Maintained
73,00 USD
-13,2%
08/06/2026
Patrick Wood
UBS
Hold
Reiterated
77,00 USD
-8,4%
08/05/2026
David Rescott
Robert W. Baird
Buy
Maintained
122,00 USD
+45,1%
08/05/2026
Unknown Analyst
UBS
Hold
Initiated
80,00 USD
-4,8%
07/28/2026
Daniel Markowitz CFA
Evercore ISI
Buy
Maintained
90,00 USD
+7,1%
07/06/2026
Rob Owens
Piper Sandler
Hold
Reiterated
63,00 USD
-25,1%
06/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
143,82 млн
160,76 млн
173,93 млн
189,95 млн
Cost of goods sold
59,25 млн
67,35 млн
72,77 млн
76,75 млн
Cost of revenue
59,25 млн
67,35 млн
72,77 млн
76,75 млн
Research and development expenses
15,26 млн
20,70 млн
24,88 млн
31,63 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46,02 млн
51,44 млн
62,98 млн
57,83 млн
Operating expense
61,28 млн
72,14 млн
87,86 млн
89,46 млн
Total operating expenses
120,52 млн
139,49 млн
160,64 млн
166,21 млн
Operating income
23,30 млн
21,27 млн
13,30 млн
23,74 млн
Other non operating income
22,00 миң
2,41 млн
258,00 миң
-6,00 миң
EBT including unusual items
23,03 млн
21,63 млн
8,48 млн
19,40 млн
EBT excluding unusual items
23,03 млн
21,63 млн
8,48 млн
19,40 млн
Income tax expense
-1,29 млн
-83,75 млн
1,17 млн
4,72 млн
Effective tax rate
-5,59%
-387,14%
13,79%
24,34%
Other operating expenses
-
-
-
-
Net income
24,32 млн
105,38 млн
7,32 млн
14,68 млн
Net profit margin
16,91%
65,55%
4,21%
7,73%
Earnings per share
0,66
0,53
0,30
0,44
Interest and investment income
3,30 млн
3,30 млн
2,70 млн
3,00 млн
Interest expense
-3,49 млн
-3,35 млн
-7,17 млн
-7,22 млн
Net interest expenses
-191,00 миң
-54,00 миң
-4,47 млн
-4,22 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
29,35 млн
28,24 млн
24,46 млн
33,18 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору